Table 2.
The results of subgroup analyses based on different Chinese patent medicines.
| Outcomes | Comparisons |
|||
|---|---|---|---|---|
| LHQW + CWT (VS CWT) | JHQG + CWT (VS CWT) | LHQK + CWT (VS CWT) | TJQW + CWT (VS CWT) | |
| Cure rate | RR = 1.19, 95 % CI 1.03–1.38, P = 0.02, 1RCT | RR = 1.42, 95 % CI 0.76–2.62, P = 0.27, 1 RCT | ||
| Aggravation rate | RR = 0.65, 95 % CI 0.28–1.53, P = 0.33, 2 RCTs | RR = 0.45, 95 % CI 0.20–1.02, P = 0.06, 1 RCT | RR = 0.16, 95 % CI 0.01–3.14, P = 0.23, 1 RCT | RR = 0.43, 95 % CI 0.12–1.60, P = 0.21, 2 RCTs |
| The recovery rate of fever | RR = 1.51, 95 % CI 1.07–2.14, P = 0.02, 1 RCT | RR = 1.00, 95 % CI 0.68–1.46, P = 1.00, 1 RCT | ||
| The recovery rate of cough | RR = 1.54, 95 % CI 0.97–2.45, P = 0.07, 1 RCT | RR = 1.42, 95 % CI 1.03–1.94, P = 0.03, 1 RCT | ||
| The recovery rate of fatigue | RR = 1.44, 95 % CI 0.98–2.11, P = 0.06, 1 RCT | RR = 1.25, 95 % CI 0.90–1.75, P = 0.19, 1 RCT | ||
| Recovery rate of chest CT manifestations | RR = 1.32, 95 % CI 1.15–1.51, P < 0.0001, 2 RCTs | RR = 1.43, 95 % CI 0.63–3.25, P = 0.40, 1 RCT | ||
| Improvement rate of chest CT manifestations | RR = 1.10, 95 % CI 0.94–1.30, P = 0.24, 1 RCT | RR = 1.35, 95 % CI 1.05–1.73, P = 0.02, 1 RCT | RR = 1.30, 95 % CI 0.97–1.74, P = 0.08, 1 RCT | |
LHQW: Lianhua Qingwen; HXZQ: Huoxiang Zhengqi; JHQG: Jinhua Qinggan; LHQK: Lianhua Qingke; TJQW: ToujieQuwen; CI: Confidence interval; RR: Risk ratio; RCT: Randomized controlled trial; VS: versus; CWT: conventional western therapy.
The forest plots of all subgroup analyses can be found in Supplement material (Supplement-Fig.3 to Supplement-Fig.9).